End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
298,000 KRW | -1.81% | -8.17% | -15.46% |
05-16 | Hanmi Pharm. Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-08 | Invion Partners with Hanlim Pharma for Glioblastoma Treatment | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
HANMI PHARM. CO., LTD. | Generic Pharmaceuticals | -1.81% | -8.17% | -15.46% | +1.49% | -18.86% | 2.77B |
Technical Rankings Surperformance
- Stock Market
- Equities
- A128940 Stock
- Charts Hanmi Pharm. Co., Ltd.
- Comparison Chart